The DOI matches its Crossref record; 330 of the 330 references it cites were found in a registry or an index.
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions
Open accessAbstract
Although Michael acceptors display a potent and broad spectrum of bioactivity, they have largely been ignored in drug discovery because of their presumed indiscriminate reactivity. As such, a dearth of information exists relevant to the thiol reactivity of natural products and their analogues possessing this moiety. In the midst of recently approved acrylamide-containing drugs, it is clear that a good understanding of the hetero-Michael addition reaction and the relative reactivities of biological thiols with Michael acceptors under physiological conditions is needed for the design and use of these compounds as biological tools and potential therapeutics. This Perspective provides information that will contribute to this understanding, such as kinetics of thiol addition reactions, bioactivities, as well as steric and electronic factors that influence the electrophilicity and reversibility of Michael acceptors. This Perspective is focused on α,β-unsaturated carbonyls given their preponderance in bioactive natural products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary clinical studies have shown that osimertinib is capable of inhibiting the L858R mutant of EGFR up to 12 nM, and the IC50 of L858R/T790M mutant was 1 nM.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [132]
In the citing paper
“The inhibition rate of osimertinib against EGFRL858R/T790M mutant was approximately 200-fold higher than that of the wild type.132”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–330 of 330
Gong, J., Vaidyanathan, V. G., Yu, X. Y., Kensler, T. W., Peterson, L. A., & Sturla, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0665951 · Cited by 53
New Prostanoids with Cytotoxic Activity from Taiwanese Octocoral Clavularia viridis
Shen, Y., Cheng, Y., Lin, Y., Guh, J., Teng, C., & Ko, C. (2004) · Journal of Natural Products · doi:10.1021/np030435a · Cited by 53
Bräse, S., Gläser, F., Kramer, C. S., Lindner, S., Linsenmeier, A. M., Masters, K., Meister, A. C., Ruff, B. M., & Zhong, S. (2013) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-7091-1312-7 · Cited by 53
Liby, K. T., Yore, M. M., Roebuck, B. D., Baumgartner, K. J., Honda, T., Sundararajan, C., Yoshizawa, H., Gribble, G. W., Williams, C. R., Risingsong, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1123 · Cited by 52
Gao, S., Tzeng, T., Sastry, M. N. V., Chu, C., Liu, J., Lin, C., & Yao, C. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.01.080 · Cited by 51
Kumar, K. J. S., Yang, H., Tsai, Y.-C., Hung, P.-C., Chang, S.-H., Lo, H.-W., Shen, P.-C., Chen, S., Wang, H., Wang, S., et al. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.04.055 · Cited by 50
Equilibrium reactions of n-butanethiol with some conjugated heteroenoid compounds
Pritchard, R. B., Lough, C. E., Currie, D. J., & Holmes, H. L. (1968) · Canadian Journal of Chemistry · doi:10.1139/v68-128 · Cited by 50
Gayarre, J., Stamatakis, K., Renedo, M., & Pérez‐Sala, D. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.069 · Cited by 50
Hypothemycin, a fungal natural product, identifies therapeutic targets in Trypanosoma brucei
Nishino, M., Choy, J. W., Gushwa, N. N., Osés-Prieto, J. A., Koupparis, K., Burlingame, A. L., Renslo, A. R., McKerrow, J. H., & Taunton, J. (2013) · eLife · doi:10.7554/elife.00712 · Cited by 49
Reactivity assessment of chalcones by a kinetic thiol assay
Amslinger, S., Al‐Rifai, N., Winter, K., Wörmann, K., Scholz, R., Baumeister, P., & Wild, M. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob27163j · Cited by 48
Chung, C. C., Ohwaki, K., Schneeweis, J. E., Stec, E. M., Varnerin, J. P., Goudreau, P. N., Chang, A., Cassaday, J., Yang, L., Yamakawa, T., et al. (2008) · Assay and Drug Development Technologies · doi:10.1089/adt.2007.105 · Cited by 48
Melampomagnolide B: A new antileukemic sesquiterpene
Nasim, S., Pei, S., Hagen, F. K., Jordan, C. T., & Crooks, P. A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.045 · Cited by 47
Kinetic Template‐Guided Tethering of Fragments
Nonoo, R. H., Armstrong, A., & Mann, D. J. (2012) · ChemMedChem · doi:10.1002/cmdc.201200404 · Cited by 47
Chan, K., Poon, R. W. M., & O’Brien, P. J. (2008) · Journal of Applied Toxicology · doi:10.1002/jat.1369 · Cited by 47
Boettcher, B. R., & Meister, A. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79675-4 · Cited by 46
Dick, R. A., Yu, X., & Kensler, T. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0162 · Cited by 46
Klüter, S., Simard, J. R., Rode, H. B., Grütter, C., Pawar, V. T., Raaijmakers, H. C. A., Barf, T. A., Rabiller, M., van Otterlo, W. A. L., & Rauh, D. (2010) · ChemBioChem · doi:10.1002/cbic.201000352 · Cited by 46
Opening or Closing the Lock? When Reactivity Is the Key to Biological Activity
Al‐Rifai, N., Rücker, H., & Amslinger, S. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201302117 · Cited by 45
Anti-selective Michael addition of thiols and their analogs to nitro olefins
Kamimura, A., Sasatani, H., Hashimoto, T., Kawai, T., Hori, K., & Ono, N. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00295a036 · Cited by 44
Eda, H., Santo, L., Cirstea, D. D., Yee, A. J., Scullen, T. A., Nemani, N., Mishima, Y. M., Waterman, P. R., Arastu‐Kapur, S., Evans, E. K., et al. (2014) · Leukemia · doi:10.1038/leu.2014.69 · Cited by 43
Cateni, F., Zilič, J., Zacchigna, M., Bonivento, P., Frausin, F., & Scarcia, V. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.10.009 · Cited by 43
Anti-inflammatory effect of lucidone in mice via inhibition of NF-κB/MAP kinase pathway
Kumar, K. J. S., Hsieh, H.-W., & Wang, S. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2009.12.013 · Cited by 42
Activity-based proteomics: enzyme chemistry redux
Kozarich, J. W. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00013-3 · Cited by 42
Wolberg, M., Dassen, B. H. N., Schürmann, M., Jennewein, S., Wubbolts, M. G., Schoemaker, H. E., & Mink, D. (2008) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.200800224 · Cited by 42
Oh, H.-M., Choi, S.-K., Lee, J. M., Lee, S. K., Kim, H.-Y., Han, D. C., Kim, H.-M., Son, K., & Kwon, B. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.029 · Cited by 41
COVALENT DRUGS FORM LONG-LIVED TIES
Guterman, L. (2011) · Chemical & Engineering News · doi:10.1021/cen-v089n036.p019 · Cited by 40
Ham, E. A., Oien, H. G., Ulm, E. H., & Kuehl, F. A. (1975) · Prostaglandins · doi:10.1016/s0090-6980(75)80075-x · Cited by 39
Antibacterial Activity and Chemical Structure of Diterpenoids
Kubo, I., Taniguchi, M., Satomura, Y., & Kubôta, T. (1974) · Agricultural and Biological Chemistry · doi:10.1080/00021369.1974.10861320 · Cited by 39
Sánchez-Gómez, F. J., Díez-Dacal, B., Pajares, M. A., Llorca, Ó., & Pérez‐Sala, D. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065391 · Cited by 39
Paasche, A., Schiller, M., Schirmeister, T., & Engels, B. (2010) · ChemMedChem · doi:10.1002/cmdc.201000020 · Cited by 39
Diterpenoids of Rabdosia Species
Fujita, E., & Node, M. (1984) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-7091-8759-3_3 · Cited by 38
Sánchez-Gómez, F. J., Gayarre, J., Avellano, M. I., & Pérez‐Sala, D. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.10.032 · Cited by 38
Urbanski, M. J., Chen, R. H., Demarest, K. T., Gunnet, J. W., Look, R., Ericson, E., Murray, W. V., Rybczynski, P. J., & Zhang, X. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.051 · Cited by 38
Kumar, K. J. S., & Wang, S. (2009) · Planta Medica · doi:10.1055/s-0029-1185309 · Cited by 37
Uesugi, S., Fujisawa, N., Yoshida, J., Watanabe, M., Dan, S., Yamori, T., Shiono, Y., & Kimura, K. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.103 · Cited by 35
Klutchko, S. R., Hoefle, M. L., Smith, R. D., Essenburg, A. D., Parker, R. B., Nemeth, V. L., Ryan, M. J., Dugan, D. H., & KAPLAN, H. R. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00133a021 · Cited by 35
Garzón, B., Oeste, C. L., Díez-Dacal, B., & Pérez‐Sala, D. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.03.028 · Cited by 35
Studies on structurally simple α,β-butenolides. III.
Camps, P., Cardellach, J., Corbera, J., Font, J., Ortuno, R. M., & Ponsatí, O. (1983) · Tetrahedron · doi:10.1016/s0040-4020(01)88539-2 · Cited by 34
Oeste, C. L., Díez-Dacal, B., Bray, F., de Lacoba, M. G., de la Torre, B. G., Andreu, D., Ruiz-Sánchez, A. J., Pérez‐Inestrosa, E., García-Domínguez, C. A., Rojas, J. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015866 · Cited by 33
Bickley, J. F., Ciucci, A., Evans, P., Roberts, S. M., Ross, N. C., & Santoro, M. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.061 · Cited by 33
Dimmock, J. R., Smith, L. M., & Smith, P. J. (1980) · Canadian Journal of Chemistry · doi:10.1139/v80-155 · Cited by 33
Covalent Reactions of Wortmannin under Physiological Conditions
Yuan, H., Barnes, K. R., Weissleder, R., Cantley, L. C., & Josephson, L. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.02.007 · Cited by 32
Redox Regulation of Protein Tyrosine Phosphatases
Parsons, Z. D., & Gates, K. S. (2013) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-405881-1.00008-2 · Cited by 32
Bohrisch, J., Faltz, H., Pätzel, M., & Liebscher, J. (1994) · Tetrahedron · doi:10.1016/s0040-4020(01)89262-0 · Cited by 32
Ayers, P. W., Yang, W., & Bartolotti, L. J. (2009) · CRC Press eBooks · doi:10.1201/9781420065442.ch18 · Cited by 32
Liu, X., Pietsch, K. E., & Sturla, S. J. (2011) · Chemical Research in Toxicology · doi:10.1021/tx2000152 · Cited by 31
Substituent Effects on the Reactivity of Benzoquinone Derivatives with Thiols
Mbiya, W., Chipinda, I., Siegel, P. D., Mhike, M., & Simoyi, R. H. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300417z · Cited by 31
Randall, M. J., Hristova, M., & van der Vliet, A. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.10.006 · Cited by 30
Novel Bruton's tyrosine kinase inhibitors currently in development
Uckun, F. M., & D'Cruz (2013) · OncoTargets and Therapy · doi:10.2147/ott.s33732 · Cited by 30
FITTON, A. O., Houghton, P. G., & SUSCHITZKY, H. (1979) · Synthesis · doi:10.1055/s-1979-28669 · Cited by 30
Aoyama, Y., Konoike, T., Kanda, A., Naya, N., & Nakajima, M. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00265-7 · Cited by 30
Synthesis and Biological Evaluation of Antitumor‐Active Arglabin Derivatives
Csük, R., Heinold, A., Siewert, B., Schwarz, Š., Barthel, A., Kluge, R., & Ströhl, D. (2011) · Archiv der Pharmazie · doi:10.1002/ardp.201100065 · Cited by 30
Zuo, Q., Li, B. J., Pei, Q., Li, Z., & Liu, S. (2010) · Journal of Fluorescence · doi:10.1007/s10895-010-0673-6 · Cited by 29
Bruegger, J. J., Haushalter, B., Vagstad, A. L., Shakya, G., Mih, N., Townsend, C. A., Burkart, M. D., & Tsai, S. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.07.012 · Cited by 29
Mondal, P., Hazarika, K. K., & Deka, R. C. (2003) · PhysChemComm · doi:10.1039/b301675g · Cited by 29
Čapková, K., Hixon, M. S., Pellett, S., Barbieri, J. T., Johnson, E. A., & Janda, K. D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.129 · Cited by 29
Reaction of antitumor hydroxymethylacylfulvene (HMAF) with thiols
McMorris, T. C., Yu, J., Estes, L. A., & Kelner, M. J. (1997) · Tetrahedron · doi:10.1016/s0040-4020(97)01064-8 · Cited by 29
A Competitive Fluorescence Assay to Measure the Reactivity of Compounds
Epps, D. E. V., & Taylor, B. M. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5173 · Cited by 28
Reactions of formylchromone derivatives. Part 2. Addition reactions of 3-(aryliminomethyl)chromones
FITTON, A. O., Frost, J. R., Houghton, P. G., & SUSCHITZKY, H. (1979) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19790001691 · Cited by 28
Kunzmann, M. H., Bach, N. C., Bauer, B., & Sieber, S. A. (2013) · Chemical Science · doi:10.1039/c3sc52228h · Cited by 28
Healy, J., Ekkerman, S., Pliotas, C., Richard, M., Bartlett, W., Grayer, S. C., Morris, G. M., Miller, S., Booth, I. R., Conway, S. J., et al. (2014) · Biochemistry · doi:10.1021/bi5001118 · Cited by 28
Xu, J., Chen, A., Joy, J. K., Xavier, V. J., Ong, E. H., Hill, J., & Chai, C. L. L. (2013) · ChemMedChem · doi:10.1002/cmdc.201300231 · Cited by 28
New α-methylene-γ-butyrolactones with antimycobacterial properties
Hughes, M. A., McFadden, J. M., & Townsend, C. A. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.119 · Cited by 28
Rates and Equilibria of the Michael-Type Addition of Benzenethiol to 2-Cyclopenten-1-ones
Castelli, V. V. A., Bernardi, F., Cort, A. D., Mandolini, L., Rossi, I., & Schiaffino, L. (1999) · The Journal of Organic Chemistry · doi:10.1021/jo9906882 · Cited by 27
Protein Reactivity of Natural Product-Derived γ-Butyrolactones
Kunzmann, M. H., Staub, I., Böttcher, T., & Sieber, S. A. (2010) · Biochemistry · doi:10.1021/bi101858g · Cited by 27
Synthesis and antileukemic activities of C1–C10-modified parthenolide analogues
Kempema, A., Widen, J. C., Hexum, J. K., Andrews, T. E., Wang, D., Rathe, S. K., Meece, F. A., Noble-Orcutt, K. E., Sachs, Z., Largaespada, D. A., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.05.037 · Cited by 26
Self-citationRoubinet, B., Renard, P., & Romieu, A. (2014) · Dyes and Pigments · doi:10.1016/j.dyepig.2014.02.004 · Cited by 26
Ha, H., Yoon, D., Park, S., & Kim, H.-J. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.08.002 · Cited by 26
Molecular Editing of Kinase‐Targeting Resorcylic Acid Lactones (RAL): Fluoroenone RAL
Jogireddy, R., Barluenga, S., & Winssinger, N. (2010) · ChemMedChem · doi:10.1002/cmdc.201000047 · Cited by 25
Canova, S., Lépine, R., Thys, A., Baron, A., & Roche, D. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.073 · Cited by 25
Kim, G.-J., Yoon, D., Yun, M.-Y., Kwon, H., Ha, H., & Kim, H.-J. (2014) · RSC Advances · doi:10.1039/c4ra01933d · Cited by 25
Thomas, B. E., & Kollman, P. A. (1995) · The Journal of Organic Chemistry · doi:10.1021/jo00131a012 · Cited by 25
Regiospecific Michael reactions to an enedione
Danishefsky, S. J., & Kahn, M. (1981) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)90135-2 · Cited by 25
Clement, L. L., Tsakos, M., Schaffert, E. S., Scavenius, C., Enghild, J. J., & Poulsen, T. B. (2015) · Chemical Communications · doi:10.1039/c5cc04500b · Cited by 25
Appendino, G., Minassi, A., Collado, J. A., Pollastro, F., Chianese, G., Taglialatela‐Scafati, O., Ayyari, M., Garcia, V., & Muñóz, E. (2015) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201500237 · Cited by 24
Highly selective fluorescence turn-on probe for glutathione
Lim, S.-Y., Lee, S., Park, S. B., & Kim, H.-J. (2011) · Tetrahedron Letters · doi:10.1016/j.tetlet.2011.05.086 · Cited by 24
Bartmann, W., Beck, G., Granzer, E., Jendralla, H., Kerékjártó, B. V., & Wess, G. (1986) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)85044-3 · Cited by 24
A-class prostaglandins: Early findings and new perspectives for overcoming tumor chemoresistance
Díez-Dacal, B., & Pérez‐Sala, D. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.003 · Cited by 24
High throughput assay for evaluation of reactive carbonyl scavenging capacity
Vidal, N., Cavaille, J. P., Graziani, F., Robin, M., Ouari, O., Pietri, S., & Stocker, P. (2014) · Redox Biology · doi:10.1016/j.redox.2014.01.016 · Cited by 23
Bowles, D. W., Senzer, N. N., Hausman, D. F., Peterson, S., Vo, A. C. H., Walker, L. N., Cohen, R. B., & Jimeno, A. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0124-3 · Cited by 23
Gao, S., Tseng, C., Tsai, C. H., & Yao, C. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.11.064 · Cited by 23
MAGNUS, P. D., & Lewis, R. T. (1989) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)99609-6 · Cited by 22
Polo, L. M., Castro, C., Cruzado, M., Collino, C., Cuello-Carrión, F. D., Ciocca, D. R., Giordano, Ó. S., Ferrari, M. M., & López, L. A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.049 · Cited by 21
Liu, X., & Sturla, S. J. (2009) · Molecular BioSystems · doi:10.1039/b904720d · Cited by 21
Design, synthesis and biological evaluation of FLT3 covalent inhibitors with a resorcylic acid core
Xu, J., Ong, E. H., Hill, J., Chen, A., & Chai, C. L. L. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.10.006 · Cited by 20
Mechanism of Action of Thalassospiramides, A New Class of Calpain Inhibitors
Lu, L., Meehan, M. J., Gu, S., Chen, Z., Zhang, W., Zhang, G., Liu, L.-L., Huang, X., Dorrestein, P. C., Xu, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep08783 · Cited by 19
Grudzinskas, C. V., & Weiss, M. J. (1973) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)95599-6 · Cited by 19
Ham, E. A., Oien, H. G., Ulm, E. H., & Kuehl, F. A. (1975) · Prostaglandins · doi:10.1016/0090-6980(75)90041-6 · Cited by 19
Fariña(rk), F., Maestro, M., Martín, M. R., Martín, M. V., Sánchez, F., & Soria, M. L. (1986) · Tetrahedron · doi:10.1016/s0040-4020(01)87341-5 · Cited by 18
Indole zum Vergleich mit Amanitagiften, III. Synthese einiger Methoxy‐oxindole und ‐indoline
Wieland, T., & Unger, O. (1963) · Chemische Berichte · doi:10.1002/cber.19630960130 · Cited by 18
Tanaka, K., Inoue, T., Tezuka, Y., & Kikuchi, T. (1996) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.44.273 · Cited by 17
3-Methyleneoxindole: An Affinity Label of Glutathione S-Transferase pi Which Targets Tryptophan 38
Pettigrew, N. E., Brush, E. J., & Colman, R. F. (2001) · Biochemistry · doi:10.1021/bi002840w · Cited by 17
Kunakbaeva, Z., Carrasco, R., & Rozas, I. (2003) · Journal of Molecular Structure THEOCHEM · doi:10.1016/s0166-1280(03)00086-1 · Cited by 17
Kakiuchi, K., Ue, M., Takeda, M., Tadaki, T., Katō, Y., Nagashima, T., Tobe, Y., Koike, H., Ida, N., & Odaira, Y. (1987) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.35.617 · Cited by 17
HAKIMELAHI, G. H., Moosavi‐Movahedi, A. A., Sambaiah, T., Zhu, J., Ethiraj, K. S., Pasdar, M., & Hakimelahi, S. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(02)01333-8 · Cited by 17
Lee, H. S., & Kim, D. H. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.08.017 · Cited by 16
Aryloxymethyl radical cyclizations mimicking biological C–C bond formation to methoxy groups
Ahmad-Junan, S. A., Walkington, A. J., & Whiting, D. A. (1992) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19920002313 · Cited by 15
Jones, J., & Middleton, H. W. (1970) · Canadian Journal of Chemistry · doi:10.1139/v70-644 · Cited by 15
Induction of G2-M phase arrest and apoptosis by α-methylene-γ-butyrolactones in human leukemia cells
Torres, F., Quintana, J., Cabrera, J., Loro-Ferrer, J. F., León, F., Bermejo, J., & Estévez, F. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.028 · Cited by 15
Progress in the chemistry of organic natural products. The chemistry of mycotoxins.
Bräse, S., Gläser, F., Kramer, C. S., et al. (2013) · PubMed · Cited by 15
Calderón, A., Font, J., & Ortuno, R. M. (1984) · Tetrahedron · doi:10.1016/s0040-4020(01)88808-6 · Cited by 14
Piaz, F. D., Nigro, P., Braca, A., DeTommasi, N., & Belisario, M. A. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.07.022 · Cited by 14
Design, synthesis, and evaluation of novel kazusamycin A derivatives as potent antitumor agents
Ando, R., Amano, Y., Nakamura, H., Arai, N., & Kuwajima, I. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.056 · Cited by 14
Mustafa, A., Asker, W., & Sobhy, M. E. E.-D. (1960) · Journal of the American Chemical Society · doi:10.1021/ja01495a051 · Cited by 14
Wells, S., Widen, J. C., Harki, D. A., & Brummond, K. M. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b02088 · Cited by 14
Self-citationCusack, K. P., Arnold, L. D., Barberis, C. E., Chen, H., Ericsson, A. M., Gaza‐Bulseco, G., Gordon, T. D., Grinnell, C. M., Harsch, A., Pellegrini, M., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.007 · Cited by 13
Reactions of 1,3,5-tris(fluorosulfonyl)benzene with some nucleophilic reagents
Kamoshenkova, O. M., & Boiko, V. N. (2009) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2009.11.019 · Cited by 13
Acid-Activatable Michael-Type Fluorescent Probes for Thiols and for Labeling Lysosomes in Live Cells
Dai, C.-G., Du, X., & Song, Q. (2015) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b02041 · Cited by 13
Target analysis of α-alkylidene-γ-butyrolactones in uropathogenic E. coli
Kunzmann, M. H., & Sieber, S. A. (2012) · Molecular BioSystems · doi:10.1039/c2mb25313e · Cited by 12
Discovery and Development of Telaprevir
Grillot, A., Farmer, L. J., Rao, B. G., Taylor, W. P., Weisberg, I. S., Jacobson, I. M., Perni, R. B., & Kwong, A. D. (2011) · Wiley eBooks · doi:10.1002/9780470929353.ch15 · Cited by 11
Gonçalves, H. P., Facundo, V. A., Santos, D. M. F., Silva, A. G. C., Ballico, L. J., Lima, D. K. S., Stábeli, R. G., & Silva-Jardim, I. (2012) · Revista Brasileira de Farmacognosia · doi:10.1590/s0102-695x2012005000086 · Cited by 11
Cis-enone Resorcylic Acid Lactones (RALs) as Irreversible Protein Kinase Inhibitors
Wei, L., Wu, J., Li, G., & Shi, N. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436395 · Cited by 11
Total synthesis of γ-trifluoromethylated analogs of goniothalamin and their derivatives
Chen, J., You, Z., & Qing, F. (2013) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2013.07.017 · Cited by 11
Thiol-Activated DNA Damage by α-Bromo-2-cyclopentenone
Fekry, M. I., Price, N. E., Zang, H., Huang, C., Harmata, M. A., Brown, P., Daniels, J. S., & Gates, K. S. (2011) · Chemical Research in Toxicology · doi:10.1021/tx100282b · Cited by 11
Local HSAB principle in the conjugate addition of p‐substituted thiophenols to cyclohexenone
Meza, R., Gordillo, B., & Galvan, M. E. (2005) · International Journal of Quantum Chemistry · doi:10.1002/qua.20577 · Cited by 11
Nagase, H. (1974) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.22.42 · Cited by 11
Design and synthesis of irreversible inhibitors of foot-and-mouth disease virus 3C protease
Roqué-Rosell, N., Mokhlesi, L., Milton, N. E., Sweeney, T. R., Zunszain, P. A., Curry, S., & Leatherbarrow, R. J. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.045 · Cited by 10
Napolitano, C., Palwai, V. R., Eriksson, L. A., & Murphy, P. V. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.04.082 · Cited by 10
Nagahara, N., Sawada, N., & Nakagawa, T. (2004) · Biochimie · doi:10.1016/j.biochi.2004.08.002 · Cited by 10
Effective irreversible alkylating reagents based on the structure of clavulones
TANAKA, H. L., Kitade, M., Iwashima, M., Iguchi, K., & Takahashi, T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.026 · Cited by 10
Catalyst‐free Efficient Synthesis of 3‐Thio‐2‐deoxysugar Derivatives in Water
Mandal, P. K., Maiti, G. H., & Misra, A. K. (2008) · Journal of Carbohydrate Chemistry · doi:10.1080/07328300802120893 · Cited by 9
Effect of oridonin, aRabdosia diterpenoid, on radiosensitization with misonidazole
Murayama, C., Nagao, Y., Sano, S., Ochiai, M., Fuji, K., Fujita, E., & Mori, T. (1987) · Cellular and Molecular Life Sciences · doi:10.1007/bf01945533 · Cited by 8
Synthesis and anticonvulsant activity of 1‐aryl‐3‐methylene‐2‐pyrrolidinone adducts
Kornet, M. J. (1985) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570220132 · Cited by 8
Regiospecific michael additions to α-methylene cyclopentenones
Siwapinyoyos, T., & Thebtaranonth, Y. (1984) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)99881-2 · Cited by 8
Chemical and biological evaluation of unusual sugars, α-aculosides, as novel Michael acceptors
Ikeda, H., Kaneko, E., Okuzawa, S., Takahashi, D., & Toshima, K. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob01877j · Cited by 7
Mustafa, A., Kamel, M., Allam, M. A., Harhash, A. H., & Hassan, A. E. A. A. (1956) · Journal of the American Chemical Society · doi:10.1021/ja01600a056 · Cited by 7
The synthesis of novel bifunctional linker molecules
Billington, S., Mann, J., Quazi, P., Alexander, R. P., Eaton, M. A. W., Millar, K., & Millican, A. T. (1991) · Tetrahedron · doi:10.1016/s0040-4020(01)87134-9 · Cited by 7
NF-κB DNA binding activity of sesquiterpene lactones fromAnthemis arvensisandAnthemis cotula
Vučković, I., Vujisić, L. V., Klaas, C. A., Merfort, I., & Milosavljević, S. (2010) · Natural Product Research · doi:10.1080/14786410902941402 · Cited by 5
Diastereoselective thiol conjugate addition on δ-alkylated-γ-silylated-α,β-unsaturated-δ-lactones
Calvet‐Vitale, S., Courillon, C., & Malacrìa, M. (2002) · ARKIVOC · doi:10.3998/ark.5550190.0003.521 · Cited by 5
垣内, 喜., 上, 真., 竹田, 充., et al. (1987) · Medical Entomology and Zoology · Cited by 1
Flagged first, then by citations
Research works printed but not linked: 6
- Parsons Z. D., 2013, Methods in Enzymology Vol. 528: Hydrogen Peroxide and Cell Signaling Part C, 528, 130
- 2014, FDA Approves Imbruvica to Treat Chronic Lymphocytic Leukemia
- gNodwell, M. B.; Sieber, S. A.Activity-Based Protein Profiling.Springer-Verlag:Berlin, 2012; Vol.324, p165;
- Atsmon J., 1990, Cancer Res., 50, 1879
- Cavalieri E., 2004, Methods in Enzymology, 382, 293
- Geroni C., 2002, Cancer Res., 62, 2332
Cited by
Sorted by citations
The Clinical KRAS(G12C) Inhibitor AMG 510 Drives Anti-Tumour Immunity
Canon, J., Rex, K., Saiki, A. Y., Mohr, C., Cooke, K., Bagal, D., Gaida, K., Holt, T., Knutson, C. G., Koppada, N., et al. (2019) · Nature · doi:10.1038/s41586-019-1694-1 · Cited by 2,277
Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects
Kotha, R. R., & Luthria, D. L. (2019) · Molecules · doi:10.3390/molecules24162930 · Cited by 960
The SARS-CoV-2 main protease as drug target
Ullrich, S., & Nitsche, C. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127377 · Cited by 787
Gehringer, M., & Laufer, S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01153 · Cited by 772
Put a ring on it: application of small aliphatic rings in medicinal chemistry
Bauer, M. R., Fruscia, P. D., Lucas, S. C. C., Michaelides, I. N., Nelson, J. E., Storer, R. I., & Whitehurst, B. C. (2021) · RSC Medicinal Chemistry · doi:10.1039/d0md00370k · Cited by 505
Metadata
- Authors
- Jackson, P. A., Widen, J. C., Harki, D. A., & Brummond, K. M.
- Affiliations
- University of Pittsburgh (US)
- University of Minnesota (US)
- Corresponding author
- Harki, Daniel A.
- Brummond, Kay M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-12-20
- Volume
- 60
- Issue
- 3
- Pages
- 839-885
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- PMC
- PMC5308545
- OpenAlex
- W2564708666
- Cited by
- 588
- References
- 329
- Citations by year
- 2026: 88 · 2025: 71 · 2024: 80 · 2023: 51 · 2022: 58 · 2021: 74 · 2020: 72 · 2019: 51 · 2018: 27 · 2017: 15
- FWCI
- 14.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01-GM054161, R01-GM110129)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Physical Organic Chemistry and Reaction Kinetics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Reactivity of Sulfur-Containing Compounds
- Keywords
- α,β-unsaturated carbonyl compounds, Michael acceptors, hetero-Michael addition, thiol reactivity, acrylamide, electrophilicity, reaction kinetics, steric and electronic effects, natural products, drug design, biological activity
- MeSH terms
- Humans, Ketones, Sulfhydryl Compounds, Drug Design, Cell Line, Tumor, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review